AUROBINDO PHARMA
Back to Balance Sheet
|
AUROBINDO PHARMA Last 5 Year Capital Work in Progress History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Capital Work in Progress | ₹2,739 Cr | ₹4,496 Cr | ₹2,938 Cr | ₹2,429 Cr | ₹1,622 Cr |
What is the latest Capital Work in Progress ratio of AUROBINDO PHARMA ?
Year | Capital Work in Progress |
---|---|
Mar2024 | ₹2,739 Cr |
Mar2023 | ₹4,496 Cr |
Mar2022 | ₹2,938 Cr |
Mar2021 | ₹2,429 Cr |
Mar2020 | ₹1,622 Cr |
How is Capital Work in Progress of AUROBINDO PHARMA Trending?
Years | Capital Work in Progress | % Change | |
---|---|---|---|
Mar2024 | ₹2,739 Cr | -39.08 | |
Mar2023 | ₹4,496 Cr | 53.07 | |
Mar2022 | ₹2,938 Cr | 20.94 | |
Mar2021 | ₹2,429 Cr | 49.77 | |
Mar2020 | ₹1,622 Cr | - |
Compare Capital Work in Progress of peers of AUROBINDO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AUROBINDO PHARMA | ₹63,667.3 Cr | -4.2% | -7.8% | -12.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹399,249.0 Cr | -1.3% | -3.3% | 8.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹174,940.0 Cr | -1.5% | 0.8% | 42.3% | Stock Analytics | |
CIPLA | ₹121,197.0 Cr | -1.7% | 2.3% | -5.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,618.0 Cr | -1.6% | 8.4% | 10.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹107,250.0 Cr | -3.3% | -1.4% | 9.8% | Stock Analytics |
AUROBINDO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AUROBINDO PHARMA | -4.2% |
-7.8% |
-12.7% |
SENSEX | 1.6% |
1% |
7% |
You may also like the below Video Courses